Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPMI Tau PET Imaging
NCT04906590Phase 2Completed
- Sponsor
- The Michael J. Fox Foundation for Parkinson's Research
- Start
- Aug 2021
- Primary completion
- Jan 2023
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by The Michael J. Fox Foundation for Parkinson's Research. Primary endpoint: [18F]PI-2620 Standard Uptake Value Ratio at 90 minutes. Started Aug 2021; status: completed.
Beyond the preview
Go deeper on NCT04906590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04906590.